EUVIMEDEUVIMED entdecken
Open Access

A Planarity‐Hindrance Co‐Balance Strategy to Develop Antiparallel H‐Aggregates With Minimal Absorbance Blueshift for Type I Photodynamic Therapy

Yubo Liu iD, Chao Ji, Zhangke Sun, Zhong-Hong Zhu iD, Ben Zhong Tang iD, Guangxue Feng iD

Advanced Materials · 2026

DOI: 10.1002/adma.73868 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Materials, 2026. Verfasst von Yubo Liu und 5 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Luminescent Materials and Devices, Guangdong Provincial Key Laboratory of Luminescence from Molecular Aggregates, School of M…. Hauptthemen laut MEDLINE: Photochemotherapy, Photosensitizing Agents, Mesoporphyrins. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Natural Science Foundation of China, National Key R&D Program of China, Key-Area Research and Development Program of Guangdong Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

H‐aggregates offer intrinsic features for type I photodynamic therapy (PDT) by concurrently promoting triplet state formation and strengthening charge transfer ability. However, their exploitation remains limited by the inherently large absorption blueshift (usually >100 nm) arising from strong H‐type excitonic coupling in conventional parallel‐packed H‐aggregates, forcing short‐wavelength laser excitation with poor tissue penetration. Herein, this study reports a planarity‐hindrance co‐balance strategy to develop donor‐π‐acceptor‐based antiparallel‐packed H‐aggregates with minimal absorption blueshift for type I PDT. The results demonstrate that π‐bridge planarization drives H‐packing, while donor‐site steric tuning dictates the blueshift by modulating slipping angles and π‐π overlapping degree, and a steric threshold (Me/OMe) is identified beyond which blueshift becomes invariant. The optimized MTBSIC molecules form H‐aggregates with an exceptionally small blueshift of 15 nm over its monomers. MTBSIC H‐aggregates further display markedly enhanced type I ROS generation and improved photothermal conversion ability over their amorphous counterparts possessing similar monomeric photophysical properties. Mechanistic analyses reveal that H‐packing promotes both intersystem crossing and intermolecular charge transfer/separation, synergistically boosting type I ROS production. MTBSIC H‐aggregates further achieve potent tumor inhibition with high biocompatibility both in vitro and in vivo. This work establishes a generalizable molecular design paradigm for near‐monomer‐like H‐aggregates for high‐performance phototheranostics.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PhotochemotherapyPhotosensitizing AgentsMesoporphyrinsAnimalsHumansReactive Oxygen Species

Stichwörter der Autor:innen

H‐aggregationaggregation‐induced emissiondonor‐π‐acceptorphotodynamic therapytype I ROS

Substanzen

Photosensitizing AgentsMesoporphyrinsReactive Oxygen Species

Autor:innen und Institutionen

  • State Key Laboratory of Luminescent Materials and Devices, Guangdong Provincial Key Laboratory of Luminescence from Molecular Aggregates, School of Materials Science and Engineering, AIE Institute, South China Universit…
  • School of Chemistry and Chemical Engineering, Guangxi Key Laboratory of Electrochemical Energy Materials, Guangxi University, Nanning, China.
  • School of Science and Engineering, Shenzhen Institute of Aggregate Science and Technology, The Chinese University of Hong Kong (Shenzhen), Shenzhen, China.

ORCID-Profile: Yubo Liu, Zhong-Hong Zhu, Ben Zhong Tang, Guangxue Feng

Förderung

  • National Natural Science Foundation of China
  • National Key R&D Program of China
  • Key-Area Research and Development Program of Guangdong Province
  • Guangdong Provincial Key Laboratory of Luminescence from Molecular Aggregates
  • National Key Research and Development Program of China

Zitieren

APA

Liu, Y., Ji, C., Sun, Z., Zhu, Z. H., Tang, B. Z., & Feng, G. (2026). A Planarity‐Hindrance Co‐Balance Strategy to Develop Antiparallel H‐Aggregates With Minimal Absorbance Blueshift for Type I Photodynamic Therapy. Advanced Materials. https://doi.org/10.1002/adma.73868

Vancouver

Liu Y, Ji C, Sun Z, Zhu ZH, Tang BZ, Feng G. A Planarity‐Hindrance Co‐Balance Strategy to Develop Antiparallel H‐Aggregates With Minimal Absorbance Blueshift for Type I Photodynamic Therapy. Advanced Materials. 2026. doi:10.1002/adma.73868

BibTeX
@article{Liu2026,
  author = {Liu, Yubo and Ji, Chao and Sun, Zhangke and Zhu, Zhong-Hong and Tang, Ben Zhong and Feng, Guangxue},
  title = {A Planarity‐Hindrance Co‐Balance Strategy to Develop Antiparallel H‐Aggregates With Minimal Absorbance Blueshift for Type I Photodynamic Therapy},
  journal = {Advanced Materials},
  year = {2026},
  doi = {10.1002/adma.73868}
}
Kostenlos starten →